4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000129
President and CEO sold 4,768 shares at $1.85 ($8,810)
- President and CEO acquired 10,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2022-09-01 | Option exercise | +10,937 | 545,327 | D | ||
| Brunn Carsten President and CEO | 2022-09-02 | Sale | −4,768 | $1.85 | $8,810 | 540,559 | D |
| Derivatives | |||||||
| Brunn Carsten President and CEO | 2022-09-01 | Option exercise · Restricted Stock Units | −10,937 | 10,938 | D | ||
| Open-market sales · 4,768 sh · avg $1.85 · $8,810 | |||||||
Loading xslF345X03/wf-form4_166251104851877.xml…